 | • レポートコード：MRC2102QY11053 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の真性多血症治療薬市場について種類別（ダサチニブ、イデラリシブ、ギビノスタット、M-009、その他）、用途別（クリニック、病院、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・真性多血症治療薬市場の概要 ・世界の主要地域別真性多血症治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の真性多血症治療薬市場規模2015-2026：種類別（ダサチニブ、イデラリシブ、ギビノスタット、M-009、その他） ・世界の真性多血症治療薬市場規模2015-2026：用途別（クリニック、病院、その他） ・真性多血症治療薬の米国市場規模2015-2020 ・真性多血症治療薬のヨーロッパ市場規模2015-2020 ・真性多血症治療薬の中国市場規模2015-2020 ・真性多血症治療薬の日本市場規模2015-2020 ・真性多血症治療薬の東南アジア市場規模2015-2020 ・真性多血症治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・真性多血症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・真性多血症治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Polycythemia Vera Drug Market
The global Polycythemia Vera Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Polycythemia Vera Drug Scope and Market Size
The global Polycythemia Vera Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polycythemia Vera Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Polycythemia Vera Drug market is segmented into
Dasatinib
Idelalisib
Givinostat
M-009
Others
Segment by Application, the Polycythemia Vera Drug market is segmented into
Clinic
Hospital
Others
The Polycythemia Vera Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Polycythemia Vera Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Polycythemia Vera Drug Market Share Analysis
Polycythemia Vera Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polycythemia Vera Drug business, the date to enter into the Polycythemia Vera Drug market, Polycythemia Vera Drug product introduction, recent developments, etc.
The major vendors covered:
ANP Technologies, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc.
Italfarmaco S.p.A.
Karus Therapeutics Limited
miRagen Therapeutics, Inc.
Nerviano Medical Sciences S.r.l.
Novartis AG
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd.
1 Polycythemia Vera Drug Market Overview
1.1 Polycythemia Vera Drug Product Scope
1.2 Polycythemia Vera Drug Segment by Type
1.2.1 Global Polycythemia Vera Drug Sales by Type (2020-2026)
1.2.2 Dasatinib
1.2.3 Idelalisib
1.2.4 Givinostat
1.2.5 M-009
1.2.6 Others
1.3 Polycythemia Vera Drug Segment by Application
1.3.1 Global Polycythemia Vera Drug Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Polycythemia Vera Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Polycythemia Vera Drug Sales Growth Rate (2015-2026)
1.4.2 Global Polycythemia Vera Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Polycythemia Vera Drug Price Trends (2015-2026)
2 Polycythemia Vera Drug Estimate and Forecast by Region
2.1 Global Polycythemia Vera Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Polycythemia Vera Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Polycythemia Vera Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Polycythemia Vera Drug Revenue Market Share by Region (2015-2020)
2.3 Global Polycythemia Vera Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Polycythemia Vera Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Polycythemia Vera Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Polycythemia Vera Drug Estimates and Projections (2015-2026)
2.4.2 Europe Polycythemia Vera Drug Estimates and Projections (2015-2026)
2.4.3 China Polycythemia Vera Drug Estimates and Projections (2015-2026)
2.4.4 Japan Polycythemia Vera Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Polycythemia Vera Drug Estimates and Projections (2015-2026)
2.4.6 India Polycythemia Vera Drug Estimates and Projections (2015-2026)
3 Global Polycythemia Vera Drug Competition Landscape by Players
3.1 Global Top Polycythemia Vera Drug Players by Sales (2015-2020)
3.2 Global Top Polycythemia Vera Drug Players by Revenue (2015-2020)
3.3 Global Polycythemia Vera Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycythemia Vera Drug as of 2019)
3.4 Global Polycythemia Vera Drug Average Price by Company (2015-2020)
3.5 Manufacturers Polycythemia Vera Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Polycythemia Vera Drug Players (Opinion Leaders)
4 Global Polycythemia Vera Drug Market Size by Type
4.1 Global Polycythemia Vera Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Polycythemia Vera Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Polycythemia Vera Drug Price by Type (2015-2020)
4.2 Global Polycythemia Vera Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Polycythemia Vera Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Polycythemia Vera Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Polycythemia Vera Drug Price Forecast by Type (2021-2026)
5 Global Polycythemia Vera Drug Market Size by Application
5.1 Global Polycythemia Vera Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Polycythemia Vera Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Polycythemia Vera Drug Price by Application (2015-2020)
5.2 Global Polycythemia Vera Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Polycythemia Vera Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Polycythemia Vera Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Polycythemia Vera Drug Price Forecast by Application (2021-2026)
6 United States Polycythemia Vera Drug Market Facts & Figures
6.1 United States Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
6.2 United States Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
6.3 United States Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
7 Europe Polycythemia Vera Drug Market Facts & Figures
7.1 Europe Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
7.2 Europe Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
7.3 Europe Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
8 China Polycythemia Vera Drug Market Facts & Figures
8.1 China Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
8.2 China Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
8.3 China Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
9 Japan Polycythemia Vera Drug Market Facts & Figures
9.1 Japan Polycythemia Vera Drug Sales Market Share by Company (3015-3030)
9.2 Japan Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
9.3 Japan Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Polycythemia Vera Drug Market Facts & Figures
10.1 Southeast Asia Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
11 India Polycythemia Vera Drug Market Facts & Figures
11.1 India Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
11.2 India Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
11.3 India Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Polycythemia Vera Drug Business
12.1 ANP Technologies, Inc.
12.1.1 ANP Technologies, Inc. Corporation Information
12.1.2 ANP Technologies, Inc. Business Overview
12.1.3 ANP Technologies, Inc. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 ANP Technologies, Inc. Polycythemia Vera Drug Products Offered
12.1.5 ANP Technologies, Inc. Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Corporation Information
12.2.2 Bristol-Myers Squibb Company Business Overview
12.2.3 Bristol-Myers Squibb Company Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Company Polycythemia Vera Drug Products Offered
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.3.2 F. Hoffmann-La Roche Ltd. Business Overview
12.3.3 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Products Offered
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 Galena Biopharma, Inc.
12.4.1 Galena Biopharma, Inc. Corporation Information
12.4.2 Galena Biopharma, Inc. Business Overview
12.4.3 Galena Biopharma, Inc. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Galena Biopharma, Inc. Polycythemia Vera Drug Products Offered
12.4.5 Galena Biopharma, Inc. Recent Development
12.5 Gilead Sciences, Inc.
12.5.1 Gilead Sciences, Inc. Corporation Information
12.5.2 Gilead Sciences, Inc. Business Overview
12.5.3 Gilead Sciences, Inc. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Gilead Sciences, Inc. Polycythemia Vera Drug Products Offered
12.5.5 Gilead Sciences, Inc. Recent Development
12.6 Italfarmaco S.p.A.
12.6.1 Italfarmaco S.p.A. Corporation Information
12.6.2 Italfarmaco S.p.A. Business Overview
12.6.3 Italfarmaco S.p.A. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Italfarmaco S.p.A. Polycythemia Vera Drug Products Offered
12.6.5 Italfarmaco S.p.A. Recent Development
12.7 Karus Therapeutics Limited
12.7.1 Karus Therapeutics Limited Corporation Information
12.7.2 Karus Therapeutics Limited Business Overview
12.7.3 Karus Therapeutics Limited Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Karus Therapeutics Limited Polycythemia Vera Drug Products Offered
12.7.5 Karus Therapeutics Limited Recent Development
12.8 miRagen Therapeutics, Inc.
12.8.1 miRagen Therapeutics, Inc. Corporation Information
12.8.2 miRagen Therapeutics, Inc. Business Overview
12.8.3 miRagen Therapeutics, Inc. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 miRagen Therapeutics, Inc. Polycythemia Vera Drug Products Offered
12.8.5 miRagen Therapeutics, Inc. Recent Development
12.9 Nerviano Medical Sciences S.r.l.
12.9.1 Nerviano Medical Sciences S.r.l. Corporation Information
12.9.2 Nerviano Medical Sciences S.r.l. Business Overview
12.9.3 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Products Offered
12.9.5 Nerviano Medical Sciences S.r.l. Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Business Overview
12.10.3 Novartis AG Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Polycythemia Vera Drug Products Offered
12.10.5 Novartis AG Recent Development
12.11 PharmaEssentia Corporation
12.11.1 PharmaEssentia Corporation Corporation Information
12.11.2 PharmaEssentia Corporation Business Overview
12.11.3 PharmaEssentia Corporation Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 PharmaEssentia Corporation Polycythemia Vera Drug Products Offered
12.11.5 PharmaEssentia Corporation Recent Development
12.12 Teva Pharmaceutical Industries Ltd.
12.12.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
12.12.3 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Products Offered
12.12.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Polycythemia Vera Drug Manufacturing Cost Analysis
13.1 Polycythemia Vera Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Polycythemia Vera Drug
13.4 Polycythemia Vera Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Polycythemia Vera Drug Distributors List
14.3 Polycythemia Vera Drug Customers
15 Market Dynamics
15.1 Polycythemia Vera Drug Market Trends
15.2 Polycythemia Vera Drug Opportunities and Drivers
15.3 Polycythemia Vera Drug Market Challenges
15.4 Polycythemia Vera Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Polycythemia Vera Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Polycythemia Vera Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Polycythemia Vera Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Polycythemia Vera Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Polycythemia Vera Drug Sales Market Share by Region (2015-2020)
Table 6. Global Polycythemia Vera Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Polycythemia Vera Drug Revenue Share by Region (2015-2020)
Table 8. Global Polycythemia Vera Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Polycythemia Vera Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Polycythemia Vera Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Polycythemia Vera Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Polycythemia Vera Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Polycythemia Vera Drug Sales Share by Company (2015-2020)
Table 14. Global Polycythemia Vera Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Polycythemia Vera Drug Revenue Share by Company (2015-2020)
Table 16. Global Polycythemia Vera Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycythemia Vera Drug as of 2019)
Table 17. Global Polycythemia Vera Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Polycythemia Vera Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Polycythemia Vera Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Polycythemia Vera Drug Players
Table 22. Global Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Polycythemia Vera Drug Sales Share by Type (2015-2020)
Table 24. Global Polycythemia Vera Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Polycythemia Vera Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Polycythemia Vera Drug Sales Share by Type (2021-2026)
Table 27. Global Polycythemia Vera Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Polycythemia Vera Drug Revenue Share by Type (2021-2026)
Table 29. Global Polycythemia Vera Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Polycythemia Vera Drug Sales Share by Application (2015-2020)
Table 32. Global Polycythemia Vera Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Polycythemia Vera Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Polycythemia Vera Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Polycythemia Vera Drug Sales Share by Application (2021-2026)
Table 36. Global Polycythemia Vera Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Polycythemia Vera Drug Revenue Share by Application (2021-2026)
Table 38. Global Polycythemia Vera Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 41. United States Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 43. United States Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 51. China Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 53. China Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 55. China Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
Table 69. India Polycythemia Vera Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Polycythemia Vera Drug Sales Market Share by Company (2015-2020)
Table 71. India Polycythemia Vera Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Polycythemia Vera Drug Sales Market Share by Type (2015-2020)
Table 73. India Polycythemia Vera Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Polycythemia Vera Drug Sales Market Share by Application (2015-2020)
Table 75. ANP Technologies, Inc. Corporation Information
Table 76. ANP Technologies, Inc. Description and Business Overview
Table 77. ANP Technologies, Inc. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. ANP Technologies, Inc. Polycythemia Vera Drug Product
Table 79. ANP Technologies, Inc. Recent Development
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Company Polycythemia Vera Drug Product
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. F. Hoffmann-La Roche Ltd. Corporation Information
Table 86. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 87. F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Product
Table 89. F. Hoffmann-La Roche Ltd. Recent Development
Table 90. Galena Biopharma, Inc. Corporation Information
Table 91. Galena Biopharma, Inc. Description and Business Overview
Table 92. Galena Biopharma, Inc. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Galena Biopharma, Inc. Polycythemia Vera Drug Product
Table 94. Galena Biopharma, Inc. Recent Development
Table 95. Gilead Sciences, Inc. Corporation Information
Table 96. Gilead Sciences, Inc. Description and Business Overview
Table 97. Gilead Sciences, Inc. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Gilead Sciences, Inc. Polycythemia Vera Drug Product
Table 99. Gilead Sciences, Inc. Recent Development
Table 100. Italfarmaco S.p.A. Corporation Information
Table 101. Italfarmaco S.p.A. Description and Business Overview
Table 102. Italfarmaco S.p.A. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Italfarmaco S.p.A. Polycythemia Vera Drug Product
Table 104. Italfarmaco S.p.A. Recent Development
Table 105. Karus Therapeutics Limited Corporation Information
Table 106. Karus Therapeutics Limited Description and Business Overview
Table 107. Karus Therapeutics Limited Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Karus Therapeutics Limited Polycythemia Vera Drug Product
Table 109. Karus Therapeutics Limited Recent Development
Table 110. miRagen Therapeutics, Inc. Corporation Information
Table 111. miRagen Therapeutics, Inc. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. miRagen Therapeutics, Inc. Description and Business Overview
Table 113. miRagen Therapeutics, Inc. Polycythemia Vera Drug Product
Table 114. miRagen Therapeutics, Inc. Recent Development
Table 115. Nerviano Medical Sciences S.r.l. Corporation Information
Table 116. Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Nerviano Medical Sciences S.r.l. Description and Business Overview
Table 118. Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Product
Table 119. Nerviano Medical Sciences S.r.l. Recent Development
Table 120. Novartis AG Corporation Information
Table 121. Novartis AG Description and Business Overview
Table 122. Novartis AG Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Novartis AG Polycythemia Vera Drug Product
Table 124. Novartis AG Recent Development
Table 125. PharmaEssentia Corporation Corporation Information
Table 126. PharmaEssentia Corporation Description and Business Overview
Table 127. PharmaEssentia Corporation Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. PharmaEssentia Corporation Polycythemia Vera Drug Product
Table 129. PharmaEssentia Corporation Recent Development
Table 130. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 131. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 132. Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Product
Table 134. Teva Pharmaceutical Industries Ltd. Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Polycythemia Vera Drug Distributors List
Table 138. Polycythemia Vera Drug Customers List
Table 139. Polycythemia Vera Drug Market Key Trends
Table 140. Polycythemia Vera Drug Key Opportunities and Drivers
Table 141. Polycythemia Vera Drug Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Polycythemia Vera Drug Product Picture
Figure 2. Global Polycythemia Vera Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Polycythemia Vera Drug Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Polycythemia Vera Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Polycythemia Vera Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Polycythemia Vera Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Polycythemia Vera Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Polycythemia Vera Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Polycythemia Vera Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Polycythemia Vera Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Polycythemia Vera Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Polycythemia Vera Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Polycythemia Vera Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Polycythemia Vera Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Polycythemia Vera Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Polycythemia Vera Drug Players Market Share by Revenue in Polycythemia Vera Drug 2015 & 2019
Figure 27. Polycythemia Vera Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Polycythemia Vera Drug Revenue Share by Type (2015-2020)
Figure 29. Global Polycythemia Vera Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Polycythemia Vera Drug Revenue Share by Application (2015-2020)
Figure 31. Global Polycythemia Vera Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 33. United States Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 34. Europe Polycythemia Vera Drug Sales Market Share by Company in 2019
Figure 35. Europe Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 36. Europe Polycythemia Vera Drug Sales Market Share by Application in 2019
Figure 37. China Polycythemia Vera Drug Sales Market Share by Company in 2019
Figure 38. China Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 39. China Polycythemia Vera Drug Sales Market Share by Application in 2019
Figure 40. Japan Polycythemia Vera Drug Sales Market Share by Company in 2019
Figure 41. Japan Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 42. Japan Polycythemia Vera Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Polycythemia Vera Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Polycythemia Vera Drug Sales Market Share by Application in 2019
Figure 46. India Polycythemia Vera Drug Sales Market Share by Company in 2019
Figure 47. India Polycythemia Vera Drug Sales Market Share by Type in 2019
Figure 48. India Polycythemia Vera Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Polycythemia Vera Drug
Figure 51. Manufacturing Process Analysis of Polycythemia Vera Drug
Figure 52. Polycythemia Vera Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …- 原発性高シュウ酸尿症薬の世界市場レポート2020 Market Analysis and Insights: Global Primary Hyperoxaluria Drug Market The global Primary Hyperoxaluria Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Primary Hyperoxaluria Drug Scope and Market Size The global Pr…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …
- 耳鳴症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Tinnitus Drug Market The global Tinnitus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tinnitus Drug Scope and Market Size The global Tinnitus Drug market is segmented by comp…